Analysts who follow Esperion Therapeutics Inc (ESPR) on average expect it to increase 253.32% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns ESPR an Analyst Ranking of 45, which means it ranks higher than 45 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating ESPR a Strong Buy today. Find out what this means to you and get the rest of the rankings on ESPR!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Esperion Therapeutics Inc Stock Today?
Esperion Therapeutics Inc (ESPR) stock is trading at $2.62 as of 11:19 AM on Thursday, Feb 8, a decline of -$0.02, or -0.57% from the previous closing price of $2.63. The stock has traded between $2.57 and $2.75 so far today. Volume today is low. So far 1,769,582 shares have traded compared to average volume of 7,326,160 shares.
Click Here to get the full Stock Report for Esperion Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
